European Medical Journal Presents: EMJ Hematology 6.1 - EMG

European Medical Journal Presents: EMJ Hematology 6.1

London, United Kingdom, August 2, 2018

The European Medical Journal has published the latest edition of the EMJ Hematology eJournal, which includes a comprehensive review of this year’s European Hematology Association (EHA) Congress, held in Stockholm, Sweden. 

This year’s eJournal presents key research, discussions, and future directions for the field of haematology. Highlights from the publication include an assortment of peer-reviewed articles on topics ranging from the use of allogeneic haematopoietic stem cell transplant and tyrosine kinase inhibitors as methods of treatment for chronic myeloid leukaemia to the latest clinical staging of mycosis fungoides and Sézary syndrome. In addition to personal insights from EMJ Hematology’s Editorial Board, a selection of hand-picked abstracts taken from the landmark 23rd annual congress of the EHA have been summarised by the presenters.   

With >11,500 attendees from around the globe making their way to Stockholm, Sweden, for EHA 2018, the programme of this year’s event combined novel findings and new developments with current care protocols to improve patient care; more programme highlights can be found as part of the extensive Congress Review detailed within our eJournal.  

EMJ Hematology 6.1 is sure to showcase fascinating content that will spark countless hours of intense debate and discussion, no doubt leading to further developments and breakthroughs for the haematology discipline.  

If you would like more information about this publication, please call Stacey Rivers at +44 (0) 1245 334450, or email [email protected].

 

Notes to Editors

About EMJ

Renowned for being the only medical journal to review the biggest European congresses, six weeks after each event is held, the European Medical Journal, is an independent, open-access eJournal dedicated to delivering first-class insights into ground-breaking changes, and advancements in the field.

Spanning sixteen therapeutic areas, including Innovations, Cardiology, Oncology, and more, each journal provides the reader with the latest from the field within our medical congress highlights, abstract reviews, and peer-reviewed articles to name but a few of its wide content selection. Flagship EMJ journals are also published quarterly, bringing an assortment of research and review papers from a variety of topics, alongside unique features and interviews. If you’re interested in receiving quarterly newsletters, and the latest publications straight to your inbox, please do subscribe for free: https://www.emjreviews.com/mailing-list/.

 

 

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.